Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Chemistry
Emerging Technology
Immunoassays
Molecular Diagnostics
Pathology & AI
Diagnostic Technologies: Page 2
Roche's breast cancer CDx receives CE Mark
By
LabPulse.com staff writers
Roche has received the CE Mark for the first companion diagnostic (CDx) test to identify patients with HER2-low metastatic breast cancer who may be eligible for treatment with Enhertu.
April 10, 2024
Labcorp expands precision oncology offerings
By
Matt Limb
Laboratory services firm Labcorp has announced the expansion of its precision oncology portfolio, aimed at supporting clinical research and advancing drug development programs.
April 12, 2024
Urine test halves use of invasive procedure to monitor bladder cancer
By
Nick Paul Taylor
A urine test can cut the number of cystoscopies necessary to follow up high-risk bladder cancer patients without increasing the risk of recurrence, a study has found.
April 11, 2024
Researchers tweak TB treatment assay to support global use
By
Nick Paul Taylor
Researchers have developed a tuberculosis (TB) treatment assay that could be a faster, simpler method for monitoring patients.
April 10, 2024
Solvd Health CEO responds to harsh letter addressing FDA, CMS
By
Liz Carey
Solvd Health CEO Dr. Keri Donaldson responded to critics of his company's machine learning classifier clinical laboratory test that uses genotyping to aid healthcare providers in OUD assessments in adults prior to first-time opioid prescriptions.
April 9, 2024
Researchers design AI model to generate new antibiotics
By
LabPulse.com staff writers
Researchers have devised an artificial intelligence (AI) model to develop potential new antibiotics which chemists can synthesize in the lab.
April 9, 2024
Quest and Broad partner for infant whole genome sequencing research
By
LabPulse.com staff writers
Quest Diagnostics and Broad Clinical Labs have announced a research collaboration exploring whole genome sequencing (WGS) on infants as a first-line genetic test for diagnosis of developmental delay disorders.
April 3, 2024
FDA clears another blood-based TBI POC test
By
LabPulse.com staff writers
Abbott furthers its point-of-care (POC) assay for measuring traumatic brain injury biomarkers from whole blood.
April 1, 2024
Researchers map protein biomarkers in sepsis fight
By
Liz Carey
Swedish researchers are mapping patterns of protein biomarkers in sepsis that could be useful for simple blood tests in the emergency department, according to research to be presented at ECCMID 2024.
April 2, 2024
Molecular diagnostic test study continues EET benefit assessment
By
Liz Carey
A molecular oncology gene expression profiling (GEP) test for breast cancer biomarkers may influence extended endocrine therapy (EET) treatment decisions, according to an impact study.
April 2, 2024
BioMérieux gets FDA 510(k) clearance, CLIA waiver approval for panel
By
LabPulse.com staff writers
BioMérieux's Biofire Spotfire Respiratory/Sore Throat Panel has received dual FDA 510(k) clearance and Clinical Laboratory Improvement Amendments (CLIA) waiver approval.
March 27, 2024
Ibex presents new study data for AI-powered cancer diagnostics platform
By
Matt Limb
Ibex Medical Analytics is hailing positive data from studies with U.S. partners on the impact of its artificial intelligence (AI)-powered cancer diagnostic platform Galen.
March 26, 2024
Previous Page
Page 2 of 311
Next Page